Cargando…

Vaccine Technologies Jockey for Primacy in Pandemic Response

Detalles Bibliográficos
Autor principal: Dolgin, Elie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935662/
https://www.ncbi.nlm.nih.gov/pubmed/33581346
http://dx.doi.org/10.1016/j.ymthe.2021.02.010
_version_ 1783661047223156736
author Dolgin, Elie
author_facet Dolgin, Elie
author_sort Dolgin, Elie
collection PubMed
description
format Online
Article
Text
id pubmed-7935662
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Society of Gene & Cell Therapy
record_format MEDLINE/PubMed
spelling pubmed-79356622022-03-03 Vaccine Technologies Jockey for Primacy in Pandemic Response Dolgin, Elie Mol Ther Perspective American Society of Gene & Cell Therapy 2021-03-03 2021-02-10 /pmc/articles/PMC7935662/ /pubmed/33581346 http://dx.doi.org/10.1016/j.ymthe.2021.02.010 Text en © 2021. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Perspective
Dolgin, Elie
Vaccine Technologies Jockey for Primacy in Pandemic Response
title Vaccine Technologies Jockey for Primacy in Pandemic Response
title_full Vaccine Technologies Jockey for Primacy in Pandemic Response
title_fullStr Vaccine Technologies Jockey for Primacy in Pandemic Response
title_full_unstemmed Vaccine Technologies Jockey for Primacy in Pandemic Response
title_short Vaccine Technologies Jockey for Primacy in Pandemic Response
title_sort vaccine technologies jockey for primacy in pandemic response
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935662/
https://www.ncbi.nlm.nih.gov/pubmed/33581346
http://dx.doi.org/10.1016/j.ymthe.2021.02.010
work_keys_str_mv AT dolginelie vaccinetechnologiesjockeyforprimacyinpandemicresponse